Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06543407 · ClinicalTrials.gov registry record · NA

Harm Reduction for Smokers With Mental Illness

A NA study of Tobacco Dependence, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06543407 is a NA study of Tobacco Dependence that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 250 participants, below the 470-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06543407, a NA study of Tobacco Dependence, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigarettes to cope with stress/distress and self-efficacy) as a potential mechanism for behavior change from SWITCH IT

Conditions Studied

Interventions

  • BEHAVIORAL SWITCH IT
  • OTHER E-cig Provision Only

Study Locations (2)

Kentucky

  • Seven Counties Services - Louisville

Rhode Island

  • The Providence Center - Providence

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-10-01
Est. Completion 2028-03-31
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT06543407

The ClinicalTrials.gov registry entry for NCT06543407 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (47% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which SWITCH IT is the first listed.

NCT06543407 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06543407 about?

NCT06543407 is a clinical study titled "Harm Reduction for Smokers With Mental Illness". To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigar...

What is the current status of trial NCT06543407?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-10-01. Estimated completion is 2028-03-31.

What conditions does trial NCT06543407 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT06543407?

The interventions under investigation include: SWITCH IT (BEHAVIORAL), E-cig Provision Only (OTHER).

Who is sponsoring clinical trial NCT06543407?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06543407 being conducted?

This trial has 2 study locations across Kentucky, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.